-+ 0.00%
-+ 0.00%
-+ 0.00%

Enanta Highlights RSV Polymerase Inhibitor Data At ESCMID 2025 In Vienna

Benzinga·04/08/2025 11:12:08
Listen to the news

 Enanta's Phase 2a Study of EDP-323 Shows Reduced Mucus and Faster Viral Clearance in RSV-Infected Adults